JP2007501627A5 - - Google Patents

Download PDF

Info

Publication number
JP2007501627A5
JP2007501627A5 JP2006523302A JP2006523302A JP2007501627A5 JP 2007501627 A5 JP2007501627 A5 JP 2007501627A5 JP 2006523302 A JP2006523302 A JP 2006523302A JP 2006523302 A JP2006523302 A JP 2006523302A JP 2007501627 A5 JP2007501627 A5 JP 2007501627A5
Authority
JP
Japan
Prior art keywords
subject
allele
genotype
osteoporosis
onset
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006523302A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007501627A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/025858 external-priority patent/WO2005013809A2/en
Publication of JP2007501627A publication Critical patent/JP2007501627A/ja
Publication of JP2007501627A5 publication Critical patent/JP2007501627A5/ja
Withdrawn legal-status Critical Current

Links

JP2006523302A 2003-08-08 2004-08-09 骨粗鬆症のための診断法および治療法 Withdrawn JP2007501627A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49386103P 2003-08-08 2003-08-08
PCT/US2004/025858 WO2005013809A2 (en) 2003-08-08 2004-08-09 Diagnostic and therapeutics for osteoporosis

Publications (2)

Publication Number Publication Date
JP2007501627A JP2007501627A (ja) 2007-02-01
JP2007501627A5 true JP2007501627A5 (enExample) 2007-03-29

Family

ID=34135292

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006523302A Withdrawn JP2007501627A (ja) 2003-08-08 2004-08-09 骨粗鬆症のための診断法および治療法

Country Status (10)

Country Link
US (1) US7723028B2 (enExample)
EP (1) EP1680513B1 (enExample)
JP (1) JP2007501627A (enExample)
KR (1) KR20060061350A (enExample)
CN (1) CN1863928A (enExample)
AT (1) ATE490339T1 (enExample)
AU (1) AU2004263184B2 (enExample)
CA (1) CA2534365A1 (enExample)
DE (1) DE602004030367D1 (enExample)
WO (1) WO2005013809A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090023147A1 (en) * 1999-08-30 2009-01-22 Kenneth Kornman Diagnostics and therapeutics for osteoporosis
US20070264645A1 (en) * 2002-01-25 2007-11-15 Kenneth Kornman IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
CN1863928A (zh) 2003-08-08 2006-11-15 英特利金遗传学有限公司 骨质疏松的诊断和治疗
US8105775B2 (en) * 2005-10-25 2012-01-31 Interleukin Genetics, Inc. IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
CA2668722A1 (en) * 2006-11-15 2008-05-22 Interleukin Genetics, Inc. The il-1 gene cluster, insulin resistance and coronary artery disease associated polymorphisms and haplotypes and methods of using same
KR100909709B1 (ko) * 2007-03-30 2009-07-30 대한민국 골밀도 및 골절 위험과 itga1 유전자 다형성과의연관성
US20100112570A1 (en) * 2008-10-22 2010-05-06 Interleukin Genetics, Inc. Genetic Markers for Weight Management and Methods of Use Thereof
WO2010083294A2 (en) * 2009-01-16 2010-07-22 Interleukin Genetics, Inc. Diagnostics and therapeutics for osteoporosis
JP2019503176A (ja) 2016-01-12 2019-02-07 インターロイキン ジェネティクス, インコーポレイテッド 処置に対する応答を予測するための方法
US10329620B2 (en) 2017-01-12 2019-06-25 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
CA3142662A1 (en) 2019-06-06 2020-12-10 Sitokine Limited Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311018D0 (en) 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
US4833080A (en) 1985-12-12 1989-05-23 President And Fellows Of Harvard College Regulation of eucaryotic gene expression
US4998617A (en) 1986-09-15 1991-03-12 Laura Lupton Inc Facial cosmetic liquid make up kit
CA1316520C (en) 1987-05-19 1993-04-20 Larry C. Hamilton Valve
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5459039A (en) 1989-05-12 1995-10-17 Duke University Methods for mapping genetic mutations
FR2650840B1 (fr) 1989-08-11 1991-11-29 Bertin & Cie Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
US6004744A (en) 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
WO1992015694A1 (en) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
WO1993011149A1 (en) 1991-12-03 1993-06-10 Thomas Jefferson University Methods of detecting a genetic predisposition for osteoporosis
US5593833A (en) 1992-07-31 1997-01-14 Garvan Institute Of Medical Research Assessment of allelic variation in vitamin D receptor correlated to bone density or turnover
JP3472587B2 (ja) 1992-08-28 2003-12-02 アベンティス ファーマ株式会社 骨関連カルボキシペプチダーゼ様タンパク質およびその製造法
EP0675903B1 (en) 1992-12-28 2004-09-29 David J Baylink Bone resorption assay
EP0679196B1 (en) 1993-01-07 2004-05-26 Sequenom, Inc. Dna sequencing by mass spectrometry
IL108947A0 (en) 1993-03-12 1994-06-24 Osteopharm Ltd Bone stimulating factor
US5593826A (en) 1993-03-22 1997-01-14 Perkin-Elmer Corporation, Applied Biosystems, Inc. Enzymatic ligation of 3'amino-substituted oligonucleotides
CA2164498C (en) 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
US5686246A (en) 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
US5942390A (en) 1996-01-12 1999-08-24 Cedars-Sinai Medical Center Method of diagnosing predisposition for ulcerative colitis in Jewish population by detection of interleukin-1 receptor antagonist polymorphism
US5698399A (en) 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis
GB9621129D0 (en) 1996-10-10 1996-11-27 Duff Gordon W Detecting genetic predisposition to sight-threatening diabetic retinopathy
GB9706359D0 (en) 1997-03-27 1997-05-14 Gemini International Holdings Polymorphisms of an il-1 receptor antagonist gene
GB9711040D0 (en) 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease
EP1212464B1 (en) 1999-08-30 2006-02-22 Interleukin Genetics, Inc. Diagnostics and therapeutics for osteoporosis
JP2002345500A (ja) * 2000-12-22 2002-12-03 Pfizer Prod Inc 炎症性障害を発展させる増加したリスクを検出するための方法および試薬
JP2005500032A (ja) * 2001-06-15 2005-01-06 インターリューキン ジェネティックス インコーポレイテッド 老化関連症状の早期発現を検出および治療する方法
CN1863928A (zh) 2003-08-08 2006-11-15 英特利金遗传学有限公司 骨质疏松的诊断和治疗

Similar Documents

Publication Publication Date Title
US12180548B2 (en) Detection of target nucleic acids using hybridization
JP2003500071A5 (enExample)
US20140349859A1 (en) Detection of target nucleic acids using hybridization
US11542556B2 (en) Single nucleotide polymorphism in HLA-B*15:02 and use thereof
JP2002533096A5 (enExample)
JP2017526347A (ja) ハイブリッド形成を使用した標的核酸の検出
EP2847593A1 (en) Methods for predicting and detecting cancer risk
RU2018122965A (ru) Улучшенный способ и набор для определения тяжести и прогрессирования периодонтального заболевания
JP2007501627A5 (enExample)
JP2011520433A5 (enExample)
Novik et al. Genetic variation in H2AFX contributes to risk of non–hodgkin lymphoma
JP2013544536A5 (enExample)
JP2006521812A5 (enExample)
JP4228041B2 (ja) 塩基多型の検出方法
US20160060696A1 (en) Method for the identification by molecular techniques of genetic variants that encode no d antigen (d-) and altered c antigen (c+w)
US20100144776A1 (en) Use of snps for the diagnosis of a pain protective haplotype in the gtp cyclohydrolase 1 gene (gch1)
Jiang et al. An improved PCR‐CTPP assay for the detection of ADH 1B Arg48His polymorphism
KR101100437B1 (ko) 단일염기 다형을 포함하는 대장암과 관련된 폴리뉴클레오티드, 그를 포함하는 마이크로어레이 및 진단 키트 및 그를 이용한 대장암의 진단방법
KR20110034297A (ko) 내인성 아토피 피부염 진단용 마커 및 그의 용도
US20140154209A1 (en) Polymorphisms associated with non-response to a hepatitis c treatment or susceptibility to non-spontaneous hepatitis c clearance
US9165108B2 (en) Probes and methods for determining the presence or absence of genetic segments
Smylie et al. Analysis of sequence variations in several human genes using phosphoramidite bond DNA fragmentation and chip-based MALDI-TOF
Tirado et al. Rapid detection of the 46C→ T polymorphism in the factor XII gene, a novel genetic risk factor for thrombosis, by melting peak analysis using fluorescence hybridization probes
CN116287199B (zh) 一种用于检测高度近视风险的引物组合、试剂盒及应用
CN103695549B (zh) 预测强直性脊柱炎易感性的试剂